Anti-VEGFR2 (Olinvacimab biosimilar) mAb (HDBS0646)
- SKU:
- HDBS0646
- Antibody Type:
- Biosimilar Reference Antibody
- Applications:
- IHC
- FC
- Drug Development
- Pharmacokinetics
- Disease Area:
- Angiogenesis
- Disease Area:
- Cancer
- Disease Area:
- Ocular Disorders
- Size:
- 100 μg
- Target:
- VEGFR2
- Isotype:
- IgG1
- Host Species:
- Whole mAb
- Reactivity:
- Human
Description
| Product Name: | Anti-VEGFR2 (Olinvacimab biosimilar) mAb |
| SKU: | HDBS0646 |
| Size: | 100 μg |
| Target: | VEGFR2 |
| Common Name: | SSS-23;SSS23;SSS 23;TTAC-0001;TTAC0001;TTAC 0001;TTAC-1;TTAC1;TTAC 1 |
| Isotype: | IgG1 |
| Host Species: | Whole mAb |
| Reactivity: | Human |
| Synonyms: | FLK1;CD309;VEGFR;VEGFR2 |
| Conjugate: | Unconjugated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
| Uniprot: | P35968 |
| Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Usage: | Research use only |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Related Products
Biotinylated Anti-VEGFR2 (Olinvacimab biosimilar) mAb (HDBS1015)
€429
Anti-VEGFR2 (Pulocimab biosimilar) mAb (HDBS0677)
€429
Biotinylated Anti-VEGFR2 (Pulocimab biosimilar) mAb (HDBS1046)
€429
Biotinylated Anti-VEGFR2 (Ramucirumab biosimilar)mAb (HDBS0268)
€429
Ramucirumab Biosimilar (Anti-VEGFR2) Antibody (HDBS0058)
€399